Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Saba Tabasum, Ph.D.

Concepts (70)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Saba Tabasum's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Saba Tabasum has written about over time.
Berberine, 1 publications between 2013 and 2013, average publication date October 2013. Melanoma, 2 publications between 2013 and 2023, average publication date October 2018. Carcinoma, Non-Small-Cell Lung, 1 publications between 2019 and 2019, average publication date February 2019. Drug Synergism, 1 publications between 2019 and 2019, average publication date February 2019. Flavonoids, 1 publications between 2019 and 2019, average publication date February 2019. Flavonols, 1 publications between 2019 and 2019, average publication date February 2019. Epithelial-Mesenchymal Transition, 4 publications between 2019 and 2022, average publication date March 2020. Wound Healing, 2 publications between 2019 and 2023, average publication date May 2021. Transforming Growth Factor beta, 2 publications between 2019 and 2023, average publication date August 2021. Amino Acyl-tRNA Synthetases, 1 publications between 2023 and 2023, average publication date October 2023. Calcium-Binding Proteins, 1 publications between 2023 and 2023, average publication date October 2023. Cell Adhesion Molecules, 1 publications between 2023 and 2023, average publication date October 2023. Skin Neoplasms, 1 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Tabasum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.